| 1 |
33537004 | Regulation of the EGFR Pathway by HSP90 Is Involved in the Pathogenesis of Cushing's Disease. | 2020 |
1 |
| 2 |
28542269 | The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells. | 2017 |
1 |
| 3 |
25115740 | Profiling Hsp90 differential expression and the molecular effects of the Hsp90 inhibitor IPI-504 in high-grade glioma models. | 2014 Dec |
1 |
| 4 |
23507703 | PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. | 2013 Jun |
1 |
| 5 |
23003202 | Lapatinib and 17AAG reduce 89Zr-trastuzumab-F(ab')2 uptake in SKBR3 tumor xenografts. | 2012 Nov 5 |
2 |
| 6 |
20940188 | Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer. | 2010 Nov 20 |
1 |
| 7 |
18199556 | Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. | 2008 Jan 15 |
1 |
| 8 |
18303439 | Expression of signaling mediators downstream of EGF-receptor predict sensitivity to small molecule inhibitors directed against the EGF-receptor pathway. | 2008 Feb |
1 |
| 9 |
18769157 | Targeting Hsp90 prevents escape of breast cancer cells from tyrosine kinase inhibition. | 2008 Sep 15 |
1 |
| 10 |
16731752 | Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT. | 2006 May |
4 |
| 11 |
16367912 | Heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin potentiates the radiation response of tumor cells grown as monolayer cultures and spheroids by inducing apoptosis. | 2005 Dec |
1 |
| 12 |
11156083 | Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin. | 2000 Dec |
2 |